278 related articles for article (PubMed ID: 19673539)
1. Computational models for drug inhibition of the human apical sodium-dependent bile acid transporter.
Zheng X; Ekins S; Raufman JP; Polli JE
Mol Pharm; 2009; 6(5):1591-603. PubMed ID: 19673539
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship for FDA approved drugs as inhibitors of the human sodium taurocholate cotransporting polypeptide (NTCP).
Dong Z; Ekins S; Polli JE
Mol Pharm; 2013 Mar; 10(3):1008-19. PubMed ID: 23339484
[TBL] [Abstract][Full Text] [Related]
3. Apical Sodium-Dependent Bile Acid Cotransporter, A Novel Transporter of Indocyanine Green, and Its Application in Drug Screening.
Wu MR; Hsiao JK
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32209977
[TBL] [Abstract][Full Text] [Related]
4. Structural requirements of the ASBT by 3D-QSAR analysis using aminopyridine conjugates of chenodeoxycholic acid.
Zheng X; Pan Y; Acharya C; Swaan PW; Polli JE
Bioconjug Chem; 2010 Nov; 21(11):2038-48. PubMed ID: 20968316
[TBL] [Abstract][Full Text] [Related]
5. Apical sodium-dependent bile acid transporter, drug target for bile acid related diseases and delivery target for prodrugs: Current and future challenges.
Li M; Wang Q; Li Y; Cao S; Zhang Y; Wang Z; Liu G; Li J; Gu B
Pharmacol Ther; 2020 Aug; 212():107539. PubMed ID: 32201314
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of genetic variants in the apical sodium-dependent bile acid transporter (ASBT; SLC10A2).
Ho RH; Leake BF; Urquhart BL; Gregor JC; Dawson PA; Kim RB
J Gastroenterol Hepatol; 2011 Dec; 26(12):1740-8. PubMed ID: 21649730
[TBL] [Abstract][Full Text] [Related]
7. ASBT(SLC10A2): A promising target for treatment of diseases and drug discovery.
Yang N; Dong YQ; Jia GX; Fan SM; Li SZ; Yang SS; Li YB
Biomed Pharmacother; 2020 Dec; 132():110835. PubMed ID: 33035828
[TBL] [Abstract][Full Text] [Related]
8. Green tea catechin EGCG inhibits ileal apical sodium bile acid transporter ASBT.
Annaba F; Kumar P; Dudeja AK; Saksena S; Gill RK; Alrefai WA
Am J Physiol Gastrointest Liver Physiol; 2010 Mar; 298(3):G467-73. PubMed ID: 20056894
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of a bacterial homologue of the bile acid sodium symporter ASBT.
Hu NJ; Iwata S; Cameron AD; Drew D
Nature; 2011 Oct; 478(7369):408-11. PubMed ID: 21976025
[TBL] [Abstract][Full Text] [Related]
10. Discovery of potent, nonsystemic apical sodium-codependent bile acid transporter inhibitors (Part 1).
Tremont SJ; Lee LF; Huang HC; Keller BT; Banerjee SC; Both SR; Carpenter AJ; Wang CC; Garland DJ; Huang W; Jones C; Koeller KJ; Kolodziej SA; Li J; Manning RE; Mahoney MW; Miller RE; Mischke DA; Rath NP; Fletcher T; Reinhard EJ; Tollefson MB; Vernier WF; Wagner GM; Rapp SR; Beaudry J; Glenn K; Regina K; Schuh JR; Smith ME; Trivedi JS; Reitz DB
J Med Chem; 2005 Sep; 48(18):5837-52. PubMed ID: 16134950
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol dependent downregulation of mouse and human apical sodium dependent bile acid transporter (ASBT) gene expression: molecular mechanism and physiological consequences.
Thomas C; Landrier JF; Gaillard D; Grober J; Monnot MC; Athias A; Besnard P
Gut; 2006 Sep; 55(9):1321-31. PubMed ID: 16484503
[TBL] [Abstract][Full Text] [Related]
12. The solute carrier family SLC10: more than a family of bile acid transporters regarding function and phylogenetic relationships.
Geyer J; Wilke T; Petzinger E
Naunyn Schmiedebergs Arch Pharmacol; 2006 Mar; 372(6):413-31. PubMed ID: 16541252
[TBL] [Abstract][Full Text] [Related]
13. Novel non-systemic inhibitor of ileal apical Na+-dependent bile acid transporter reduces serum cholesterol levels in hamsters and monkeys.
Kitayama K; Nakai D; Kono K; van der Hoop AG; Kurata H; de Wit EC; Cohen LH; Inaba T; Kohama T
Eur J Pharmacol; 2006 Jun; 539(1-2):89-98. PubMed ID: 16687134
[TBL] [Abstract][Full Text] [Related]
14. Arylsulfonylamino-benzanilides as inhibitors of the apical sodium-dependent bile salt transporter (SLC10A2).
Liu HT; He HW; Bai XG; Wang JX; Xu CL; Cai SY; Shao RG; Wang YC
Molecules; 2013 Jun; 18(6):6883-97. PubMed ID: 23752471
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a highly potent, nonabsorbable apical sodium-dependent bile acid transporter inhibitor (GSK2330672) for treatment of type 2 diabetes.
Wu Y; Aquino CJ; Cowan DJ; Anderson DL; Ambroso JL; Bishop MJ; Boros EE; Chen L; Cunningham A; Dobbins RL; Feldman PL; Harston LT; Kaldor IW; Klein R; Liang X; McIntyre MS; Merrill CL; Patterson KM; Prescott JS; Ray JS; Roller SG; Yao X; Young A; Yuen J; Collins JL
J Med Chem; 2013 Jun; 56(12):5094-114. PubMed ID: 23678871
[TBL] [Abstract][Full Text] [Related]
16. Structural determinants for transport across the intestinal bile acid transporter using C-24 bile acid conjugates.
Rais R; Acharya C; Mackerell AD; Polli JE
Mol Pharm; 2010 Dec; 7(6):2240-54. PubMed ID: 20939504
[TBL] [Abstract][Full Text] [Related]
17. Weanling, but not adult, rabbit colon absorbs bile acids: flux is linked to expression of putative bile acid transporters.
Weihrauch D; Kanchanapoo J; Ao M; Prasad R; Piyachaturawat P; Rao MC
Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G439-50. PubMed ID: 16166347
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis.
Baghdasaryan A; Fuchs CD; Österreicher CH; Lemberger UJ; Halilbasic E; Påhlman I; Graffner H; Krones E; Fickert P; Wahlström A; Ståhlman M; Paumgartner G; Marschall HU; Trauner M
J Hepatol; 2016 Mar; 64(3):674-81. PubMed ID: 26529078
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ileal bile acid transport and reduced atherosclerosis in apoE-/- mice by SC-435.
Bhat BG; Rapp SR; Beaudry JA; Napawan N; Butteiger DN; Hall KA; Null CL; Luo Y; Keller BT
J Lipid Res; 2003 Sep; 44(9):1614-21. PubMed ID: 12810816
[TBL] [Abstract][Full Text] [Related]
20. Gut-restricted apical sodium-dependent bile acid transporter inhibitor attenuates alcohol-induced liver steatosis and injury in mice.
Matye DJ; Li Y; Chen C; Chao X; Wang H; Ni H; Ding WX; Li T
Alcohol Clin Exp Res; 2021 Jun; 45(6):1188-1199. PubMed ID: 33885179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
